Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,527 across all filing types
Latest filing 2013-03-15 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
TRADING HALT
Regulatory Filings Classification · 95% confidence The document is a short announcement from CSPC Pharmaceutical Group Limited regarding a trading halt on its shares on the Hong Kong Stock Exchange. It states the trading halt is pending the release of an announcement related to inside information. The document is brief (1299 characters), contains no financial data or detailed report content, and serves as a regulatory notification. It does not contain or attach any financial report or detailed management information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2013-03-15 English
EXCHANGE NOTICE - TRADING HALT
Regulatory Filings Classification · 95% confidence The document is a short exchange notice regarding a trading halt for CSPC Pharmaceutical Group Limited. It does not fit into specific categories like earnings, dividends, or reports. As it is a regulatory announcement regarding market activity that does not fall into other specific categories, it is classified as a general regulatory filing.
2013-03-15 English
Monthly return of equity issuer on movements in securities for the month ended 28 February 2013
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28/02/2013, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content focuses on changes in the company's capital structure and share issuance activities during the month. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements, typical for compliance with exchange rules. It is not an annual or interim report, earnings release, or management report. Given the detailed nature of share capital movements and the monthly frequency, this fits the category of Share Issue/Capital Change (SHA). The document length is substantial and contains substantive data on share capital changes, not merely an announcement or certification, so it is not RPA or RNS.
2013-03-06 English
NEW MEMORANDUM AND NEW ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document contains multiple special and ordinary resolutions passed at general meetings of China Pharmaceutical Group Limited (now CSPC Pharmaceutical Group Limited). It includes amendments to the Articles of Association, changes in authorized share capital, approval of acquisition agreements, and other corporate governance matters. The presence of resolutions passed at Annual General Meetings and Extraordinary General Meetings, focusing on company governance, share capital changes, and corporate structure, indicates this is a filing related to shareholder meeting resolutions and governance changes. It is not a full annual report, earnings release, or audit report. It is not a proxy solicitation or voting results announcement but rather the formal resolutions passed at meetings. Therefore, the document best fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices, including amendments to articles of association and special resolutions.
2013-03-06 English
CHANGE OF NAME, STOCK SHORT NAME, LOGO AND WEBSITE OF THE COMPANY
Regulatory Filings Classification · 95% confidence The document is an announcement from CSPC Pharmaceutical Group Limited regarding changes to the company's name, stock short name, logo, and website. It references prior announcements and shareholder approval at an Extraordinary General Meeting (EGM). The content is about corporate identity changes and stock trading name updates, not about financial results, management changes, or detailed reports. The document is relatively short (2935 characters) and serves as an official announcement of these changes rather than a detailed report or presentation. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2013-03-04 English
POLL VOTING RESULT OF EXTRAORDINARY GENERAL MEETING HELD ON 21 FEBRUARY 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the poll voting results from an Extraordinary General Meeting (EGM) held on 21 February 2013. It details the voting outcome for a special resolution regarding the proposed change of the company's name. The document does not contain financial statements, management discussion, or detailed report content. It is a formal announcement of voting results, referencing the EGM and the resolution passed. The document length is short (2854 characters), and it serves to inform shareholders and the public of the voting outcome rather than presenting a full report or detailed financial data. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2013-02-21 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.